Investigating the Clinical Factors and Co‐medications Associated With Circulating Levels of Atorvastatin and Its Major Metabolites in Secondary Prevention

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.14133
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Atorvastatin Inhibits Gp91phox Circulating Levels in Patients With Hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

Major Factors in the Spread of Grazing and Problems Associated With Its Expansion

Geographical review of Japan series A
2010English

Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

MicroRNAs Associated With Secondary Metabolites Production

2019English

Circulating Levels of Cyclooxygenase Metabolites in experimentalTrypanosoma Cruziinfections

Mediators of Inflammation
ImmunologyCell Biology
2004English

Gender-Related Differences in Circulating Levels of Adipocytokine Associated With Postoperative Complication Following Major Surgery

Journal of Nippon Medical School
Medicine
2009English

Clinical Factors Associated With Circulating Tumor DNA (ctDNA) in Primary Breast Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Poverty-Related Factors Associated With Obesity Prevention Policies in Utah Secondary Schools

Journal of the American Dietetic Association
2008English

The Levels of Circulating Proangiogenic Factors in Migraineurs

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy